BRKRP
VCYT

Bonnie H. Anderson

Known title: Executive ChairwomanCIK: 0001588970

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

BRKR risk highlighted in recent market analysis. A recent article discusses why Bruker (BRKR) is considered risky, suggesting alternative stocks. This commentary focuses on the parent company's common stock, which may influence sentiment for its preferred shares. The preferred stock has a low dividend yield and trades within a wide 52-week range.

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 11, 2026

Veracyte (VCYT) Stock Seen as Undervalued After 107% Rise. Recent coverage notes that Veracyte’s shares have risen more than 100% while still appearing inexpensive relative to its earnings multiple. The company’s trailing P/E of about 30.6 and an analyst consensus target near $58 suggest the market may be pricing in further upside. The stock is currently trading near the lower end of its 52‑week range, close to a support level that has been tested multiple times.

this person other insiders at VCYT

Transaction History

BRKRP▲ Buy$0
BRKRP▲ Buy$0
BRKRP▲ Buy$0
VCYT▼ Sell$35K
VCYT▲ Buy$191K
VCYT▼ Sell$749K
VCYT▲ Buy$191K
VCYT▼ Sell$774K
VCYT▼ Sell$217K
VCYT▲ Buy$191K
VCYT▼ Sell$120K
VCYT▼ Sell$776K
VCYT▲ Buy$907K
VCYT▼ Sell$1.6M
BRKRP▲ Buy$0
VCYT▼ Sell$60K
VCYT▲ Buy$717K
VCYT▲ Buy$168K
VCYT▼ Sell$960K
VCYT▼ Sell$1.3M
VCYT▲ Buy$84K
VCYT▲ Buy$16K
VCYT▼ Sell$39K
VCYT▼ Sell$1.1M
VCYT▼ Sell$160K
VCYT▼ Sell$2.1M
VCYT▼ Sell$37K
VCYT▼ Sell$15K
VCYT▲ Buy$0
VCYT▼ Sell$126K
BRKRP▲ Buy$0
VCYT▲ Buy$100K
VCYT▼ Sell$90K
VCYT▼ Sell$130K
VCYT▼ Sell$95K
VCYT▼ Sell$121K

We use analytics to understand how market-wall is used. No personal data is sold.